Well done to the team at Reynolds American Inc. for gaining FDA authorisation for the sale of Vuse Alto with Golden Tobacco and Rich Tobacco flavours 👏
The FDA has authorised the marketing and sale of Vuse Alto with Golden Tobacco and Rich Tobacco flavours in the United States. This is good news for adult smokers, who do not want to quit, and for public health. We know that sustained and lasting changes to adult consumer behaviour offer the greatest hope for making cigarettes obsolete. We believe that adult smokers should be given freedom over their decision to quit smoking and must be given the option to switch to alternatives that are backed by #science. BAT now has the largest vapour portfolio in the U.S. with Vuse Alto, Vuse Vibe, Vuse Ciro and Vuse Solo – supporting our ambition to Build a Smokeless World and become a predominately smokeless business by 2035. The FDA requires submissions (PMTAs) to include a significant amount of evidence: from data that summarises the health impact of the new products, to the impact on the population as a whole, including users of the new product and non-users of tobacco products. As part of its 500,000 page submission to the FDA, Reynolds American Inc. submitted the interim results of a 24 month study termed the Longitudinal Tobacco Use and Transitions Survey (LTTS) of Vuse products. The interim results, presented at the FDLI conference in March 2023, show that nearly 45% of participants who use Vuse Alto completely switched away from cigarettes (link to the presentation: https://lnkd.in/ec9VK2Hh). Well done to Christopher Junker, the Regulatory Science Team and everyone at Reynolds American Inc. who contributed to the submission. 👏 👏 👏 Link to press release: https://lnkd.in/ejghc_WX